Sprache auswählen
Kostenlose Registrierung
Mein Warenkorb

CD8

CD8 Molekülinformation

Englischer NameCluster of differentiation 8Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel18Target-AliasCD8 Antigens
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical
Englischer NameCluster of differentiation 8
Target-AliasCD8 Antigens
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel18
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical

CD8 Produktliste

  • Attribut

    Antibody (1)Cell Grade Beads (1)

  • Produktbibliothek

    Online (2)

  • Spezies

    Mouse (1)Human (1)

  • Etikett

    - (2)

  • Marker

    APC-CY7 Labeled (1)- (1)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
MBS-S005
Human
-
Cellectra™ Human CD8 NanoSort Microbeads, Research grade In den Warenkorb legen
FABm003-05
Mouse
-
APC-CY7-Labeled Monoclonal Anti-Human CD8 Antibody, Mouse IgG1 In den Warenkorb legen
Gesamtmenge2
  • 1

CD8 Molekülalias

CD8

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
89Zr-Df-crefmirlimabIAB-22-M2CPhase 3 ClinicalImaginab IncCarcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Leukoencephalopathy, Progressive Multifocal; Lymphoma; Melanoma; Multiple Sclerosis; Skin Melanoma; Solid tumours
Details
RB-0003RB-0003; BNT-111Phase 2 ClinicalBiontech Se, TronMelanoma
Details
CD8+ memory T cell therapy (Stanford University)Phase 2 ClinicalStanford UniversityLeukemia; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Details
GEN-009GEN-009Phase 2 ClinicalGenocea Biosciences IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Skin Melanoma; Squamous Cell Carcinoma of Head and Neck
Details
VE-800VE-800Phase 2 ClinicalVedanta Biosciences IncColorectal Neoplasms; Gastroesophageal Junction Neoplasms; Melanoma; Neoplasm Metastasis; Stomach Neoplasms
Details
EBViNT Cell (Eutilex)Phase 2 ClinicalEutilexLymphoma, Extranodal NK-T-Cell
Details
ZED88082AZED88082APhase 2 ClinicalUmcg The University Medical Center GroningenNeoplasm Metastasis; Neoplasms
Details
AZD-6750AZD6750; AZD-6750Phase 2 ClinicalAstrazeneca PlcCarcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Cystadenocarcinoma, Serous; Melanoma; Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms
Details
AZD-9793AZD9793; AZD-9793Phase 2 ClinicalAstrazeneca PlcCarcinoma, Hepatocellular; Neoplasm Metastasis; Solid tumours
Details
AZD-5492AZD5492Phase 2 ClinicalAstrazeneca PlcArthritis, Rheumatoid; Leukemia, B-Cell; Lupus Erythematosus, Systemic; Lymphoma, B-Cell; Myositis; Neoplasms
Details
SNA-00668-Ga-NODAGA-SNA-006; 68Ga-NODAGA-SNA006; SNA-006Phase 2 ClinicalSmartnuclide BiopharmaNeoplasms; Solid tumours
Details
NY-ESO-1-specific autologous CD8+ T-cell therapy (Fred Hutchinson Cancer Research Center)Phase 1 ClinicalFred Hutchinson Cancer Research Center, National Cancer InstituteLiposarcoma; Sarcoma; Sarcoma, Synovial
Details
MTX-101 (Mozart Therapeutics)MTX-101 (Mozart Therapeutics)Phase 1 ClinicalMozart Therapeutics IncAutoimmune Diseases; Diabetes Mellitus, Type 1
Details
[18F]GEH200521GEH200521 (18F); GEH-200521Phase 1 ClinicalGe HealthcareSolid tumours
Details
Tcrx T cell Therapy(Second Affiliated Hospital School Of Zhejiang University School Of Medicine)Phase 1 ClinicalSecond Affiliated Hospital School Of Zhejiang University School Of MedicineGastroesophageal Junction Neoplasms; Stomach Neoplasms
Details
SCRI-E2CAR_EGFRtv1SCRI-E2CAR_EGFRtv1Phase 1 ClinicalUmoja BioPharma IncOsteosarcoma
Details
89Zr-DFO-REGN505489Zr-DFO-REGN5054Phase 1 ClinicalRegeneron Pharmaceuticals IncSolid tumours
Details
AGX-148AGX-148; AGX148Phase 1 ClinicalAgonOx IncColorectal Neoplasms; Genital Neoplasms, Female; Lung Neoplasms; Melanoma; Neoplasms; Squamous Cell Carcinoma of Head and Neck; Urogenital Neoplasms
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Teilen auf:

Mach mitRechtliche HinweiseSeitenübersichtDatenschutzrichtlinieTerms and Conditions
Website-Feedback
Kontaktieren Sie uns

+49 800 0826645

order.de@acrobiosystems.com
tech.de@acrobiosystems.com

BettinastraBe 30, 60325 Frankfurt am Main